PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40
Media Pack
News

Current Edition

Volume 16, Issue 4
Nasal & Pulmonary Drug Development
Staubli 11 March 2024, 13:59
Catalent: Mon 28 October 2024, 13:21
Novo Nordisk 20 March 2024, 11:21
Biosynth: Fri 4 October 2024, 10:42
Lessons Learned in Developing Cardiovascular and Metabolic Drugs: Introduction to the Series
Special Feauture v4i3

Lessons Learned in Developing Cardiovascular and Metabolic Drugs: Introduction to the Series

Paul Strumph, Rick Turner and Associates at Quintiles introduce a new Commentary Series entitled Lessons Learned in Developing Cardiovascular and Metabolic Drug...
26 September 2012 Special Feauture v4i3 | Volume 4 Issue 3 cardiovascular | clinical trial
Continue Reading →
Product Liability: Navigating a Restrictive Market
Special Feauture v4i3

Product Liability: Navigating a Restrictive Market

Insurers are facing a growing number of product liability claims in what is becoming an increasingly litigious environment in the UK and Europe. Stricter regulat...
26 September 2012 Special Feauture v4i3 | Volume 4 Issue 3 liability | market
Continue Reading →
SAE Media: Fri 25 October 2024, 10:33
PHARMAP: Mon 14 October 2024, 10.36
Automa: Mon 14 October 2024, 10:22
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Stoelzle Skyscraper: 27th November 2024
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35
Novonordisk: Wed 17 July 2024, 13:49
logo-ipi-w.png

International Pharmaceutical Industry

IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative

Facebook Linkedin Tumblr
IPI Media © 2025, All Rights Reserved – Powered by Teksyte